Janiczek Wealth Management LLC Has $126,000 Stock Position in Chemed Co. (NYSE:CHE)

Janiczek Wealth Management LLC increased its holdings in shares of Chemed Co. (NYSE:CHE) by 154.5% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 196 shares of the company’s stock after purchasing an additional 119 shares during the period. Janiczek Wealth Management LLC’s holdings in Chemed were worth $126,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in CHE. Wellington Management Group LLP lifted its holdings in shares of Chemed by 0.3% in the third quarter. Wellington Management Group LLP now owns 386,237 shares of the company’s stock valued at $200,727,000 after purchasing an additional 1,044 shares in the last quarter. JPMorgan Chase & Co. grew its position in shares of Chemed by 9.2% in the third quarter. JPMorgan Chase & Co. now owns 287,386 shares of the company’s stock valued at $149,355,000 after purchasing an additional 24,161 shares in the last quarter. TD Asset Management Inc grew its position in shares of Chemed by 164.3% in the fourth quarter. TD Asset Management Inc now owns 205,777 shares of the company’s stock valued at $120,328,000 after purchasing an additional 127,934 shares in the last quarter. Massachusetts Financial Services Co. MA boosted its stake in Chemed by 121.5% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 203,096 shares of the company’s stock valued at $118,760,000 after buying an additional 111,399 shares during the period. Finally, Victory Capital Management Inc. boosted its stake in Chemed by 19.7% during the fourth quarter. Victory Capital Management Inc. now owns 188,679 shares of the company’s stock valued at $110,330,000 after buying an additional 31,036 shares during the period. Institutional investors and hedge funds own 95.85% of the company’s stock.

Insider Activity

In other news, Director Patrick P. Grace sold 284 shares of the stock in a transaction on Wednesday, June 12th. The stock was sold at an average price of $540.98, for a total transaction of $153,638.32. Following the transaction, the director now directly owns 3,270 shares of the company’s stock, valued at approximately $1,769,004.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In other news, Director Patrick P. Grace sold 284 shares of the company’s stock in a transaction on Wednesday, June 12th. The stock was sold at an average price of $540.98, for a total value of $153,638.32. Following the completion of the sale, the director now directly owns 3,270 shares in the company, valued at approximately $1,769,004.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Kevin J. Mcnamara sold 1,500 shares of the company’s stock in a transaction on Thursday, June 6th. The stock was sold at an average price of $544.17, for a total value of $816,255.00. Following the completion of the sale, the chief executive officer now owns 107,049 shares of the company’s stock, valued at $58,252,854.33. The disclosure for this sale can be found here. Insiders have sold 5,784 shares of company stock valued at $3,240,053 in the last ninety days. 3.32% of the stock is currently owned by company insiders.

Chemed Stock Performance

Shares of Chemed stock traded up $1.15 during midday trading on Thursday, hitting $542.38. The company had a trading volume of 16,523 shares, compared to its average volume of 80,670. The stock has a market capitalization of $8.21 billion, a P/E ratio of 29.13, a P/E/G ratio of 2.21 and a beta of 0.46. The company has a 50 day moving average of $559.54 and a 200 day moving average of $589.46. Chemed Co. has a 52-week low of $492.84 and a 52-week high of $654.62.

Chemed (NYSE:CHE) last released its quarterly earnings data on Wednesday, April 24th. The company reported $4.68 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.09 by ($0.41). The business had revenue of $589.23 million during the quarter, compared to the consensus estimate of $587.18 million. Chemed had a net margin of 12.36% and a return on equity of 30.52%. Equities research analysts forecast that Chemed Co. will post 21.54 EPS for the current year.

Chemed Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 18th. Investors of record on Thursday, May 30th were given a $0.40 dividend. The ex-dividend date of this dividend was Thursday, May 30th. This represents a $1.60 annualized dividend and a yield of 0.29%. Chemed’s dividend payout ratio (DPR) is presently 8.61%.

Analyst Ratings Changes

Several brokerages have issued reports on CHE. StockNews.com raised Chemed from a “hold” rating to a “buy” rating in a research note on Saturday, May 4th. Oppenheimer boosted their price target on Chemed from $625.00 to $650.00 and gave the company an “outperform” rating in a report on Thursday, February 29th. Finally, Royal Bank of Canada reduced their target price on Chemed from $712.00 to $697.00 and set an “outperform” rating on the stock in a report on Tuesday, May 21st.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.